MANE
Veradermics, Incorporated
NYSE: MANE · HEALTHCARE · BIOTECHNOLOGY
$99.00
-7.09% today
Updated 2026-04-30
Market cap
$3.74B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.37
Dividend yield
—
52W range
$32 – $110
Volume
0.5M
Veradermics, Incorporated (MANE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | $-13.51M | $-23.69M | $-71.60M |
| Capital expenditures | $0.00 | $0.00 | $24000.00 |
| Depreciation | — | — | — |
| Stock-based comp | $206000.00 | $250000.00 | $1.44M |
| Free cash flow | $-13.51M | $-23.69M | $-71.63M |
| Investing cash flow | — | — | — |
| Financing cash flow | — | — | — |
| Dividends paid | — | — | — |
| Share repurchases | — | — | — |
| Debt repayment | — | — | — |
| Net change in cash | — | — | — |